Oasmia Pharmaceuticals Says Survival Data From A Phase 3 Study Met Endpoint, Shares Gain 5%
April 27, 2016 at 10:43 AM EDT
Shares of Oasmia Pharmaceutical AB - American Depositary Shares (NASDAQ: OASM), a Sweden-based developer and manufacturer of drugs in ...